Frequency Therapeutics, Inc. (NASDAQ:FREQ – Get Free Report) shares traded down 9.4% during trading on Monday . The stock traded as low as $0.37 and last traded at $0.38. 140,223 shares were traded during mid-day trading, a decline of 85% from the average session volume of 953,900 shares. The stock had previously closed at $0.42.
Frequency Therapeutics Stock Performance
The company has a 50 day moving average price of $0.54 and a 200 day moving average price of $0.46. The company has a market capitalization of $14.02 million, a price-to-earnings ratio of -0.20 and a beta of 0.70.
Frequency Therapeutics (NASDAQ:FREQ – Get Free Report) last issued its earnings results on Thursday, August 10th. The company reported ($0.30) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.14. Research analysts forecast that Frequency Therapeutics, Inc. will post -1.7 EPS for the current year.
Hedge Funds Weigh In On Frequency Therapeutics
About Frequency Therapeutics
Frequency Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue.
- Five stocks we like better than Frequency Therapeutics
- Most Volatile Stocks, What Investors Need to Know
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- How to Invest in Fertilizer
- 5 Reasons Mullen Automotive is About to Turn a Corner
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for Frequency Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Frequency Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.